Confidentiality from the first contact
A non-disclosure agreement (NDA) before any exchange of product data.
Every project is scoped individually. This is the path from your first message to a written proposal.
Start with a short messageTell us about the product and the regulatory goal. No confidential data is needed at this stage.
We read your request and come back with times for a diagnostic meeting.
If you want to discuss product data in the first meeting, we sign a mutual NDA before it. Otherwise the first conversation stays non-confidential.
A video meeting to understand your program, target agency, existing data and timeline.
If needed, you share the documents that let us size the work.
Scope, deliverables, timeline, fee and engagement model, with assumptions and what is out of scope.
A non-disclosure agreement (NDA) before any exchange of product data.
Every conclusion referenced to its source, ready for questions from agencies and auditors.
No account-management layers: the person you talk to is the person who does the work.
Documents and meetings in the language of your team and of the target agency.
Scope, deliverables and fee defined in the proposal. Ideal for a gap analysis, an FIH package, a waiver justification or a set of CTD modules.
Fractional toxicologist or NAMs radar, with a fixed monthly or quarterly fee.
An independent opinion on documents or strategies prepared by your team or by third parties.
The fee depends on the size of the regulatory question, the amount and quality of existing data, the target agencies, the deliverable and the timeline. You receive a written proposal with a defined scope and fee.
Yes. We work remotely, in English or Portuguese, for clients in Brazil and abroad.
A non-disclosure agreement (NDA) is signed before any technical information is sent.
Yes. If you want to discuss product data in the diagnostic meeting, we sign a mutual NDA before it.
In some cases, yes. When the literature and existing data are sufficient, and with the support of qualified non-animal methods, a reduced nonclinical package can be justified. D-Sci assesses your case and builds that rationale; the final decision rests with the regulatory agency.
Not directly. D-Sci designs the studies, guides the laboratories, oversees execution at the CROs and interprets the results. Execution is carried out by partner laboratories or by the CRO of your choice.
You contract a monthly package of hours and use it as the program needs: questions, reviews, study oversight and documents.
It depends on the scope and on data availability. The timeline is defined in the proposal.
Each project receives a tailored proposal after the diagnostic meeting, which is free of charge.
No-cost diagnostic meeting. NDA available before we talk.
Talk to D-Sci